MedTrace Logo

Development of Workplace Physical Activity Promotion Models in Taiwan

NCT02215239 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2015-03-17

No results posted yet for this study

Summary

The purpose of this study is to investigate the effectiveness of intervention applying WHO Healthy Workplace Framework and Model to enhance the level of physical activity on employees. This research is an experimental intervention study recruiting two working types in four workplaces. Two working types are: (1) Working type A: Workers tend to be seated during work hours. Two telecommunications enterprises will respectively stand for the experiment group and the control group. (2) Working type B: Workers tend to be standing during work hours. Likewise, two different enterprises will respectively stand for the experiment group and the control group. Purposive sampling method will be used to select the experiment group. The intervention plan is to implement a cyclic or iterative process recommended by WHO.

Conditions

  • Occupational Health

Interventions

BEHAVIORAL

Workplace intervention

WHO Healthy Workplace Framework and Model. The intervention plan is to implement a cyclic or iterative process recommended by WHO. The process includes eight steps: (1) Mobilize; (2) Assemble; (3) Assess; (4) Prioritize; (5) Plan; (6) Do; (7) Evaluate; (8) Improve. We focus on different phases of exercise and prescribe individualized physical activity program.

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Meng-Yueh Chien · National Taiwan University Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02215239 on ClinicalTrials.gov